尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the complete record of transactions filed by Al-Wakeel Yasir B., 首席财务官. Director active across 2 companies, notably Kronos Bio, Inc.. Aggregated, 8 disclosures have been recorded. Breakdown: 0 buy · 2 sells. Total volume traded: €30k. Activity tracked since 15 February 2022. The latest transaction was disclosed on 18 June 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 条申报中的 8 条
Al-Wakeel Yasir B. is Director Financier and is associated with Kronos Bio, Inc. as Chief Financial Officer and with Maxcyte, INC. as Director. Across 8 filings, the 8 sampled filings run from 2022-02-17 to 2026-06-22, with EUR 30254 in sales and EUR 0 in purchases; the modal transaction nature is Attribution.